As knowledge about Covid-19 advances, so does the arsenal of techniques to predict, diagnose and follow up on the disease. At this year’s ECR, researchers presented a range of promising imaging modalities to keep track of Covid-19 symptoms, severity, and mortality, often including AI support to enhance or accelerate diagnostics.
Dark-field radiography uses a part of X-rays that has hardly been considered so far to expand the spectrum of diagnostic imaging. At the ECR Overture, Theresa Urban presented the new method.
Using functional MRI with inhaled xenon gas, researchers have identified that long COVID symptoms are related to microscopic abnormalities that affect how oxygen is exchanged from the lungs to the red blood cells.
A research group from Kyoto developed two in vitro models to study SARS-CoV-2, and showed that they can be used for drug screening for infectious diseases including Covid-19.
A simple blood test could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.
A special type of MRI found lung abnormalities in patients who had previously had COVID-19, even those who had not been hospitalized with the illness.
Advances in image post-processing and contrast-enhanced techniques have widened the scope of possibilities for MRI and ultrasound vascular imaging, experts showed in a dedicated course at the ECR Overture.
Scientists at the La Jolla Institute for Immunology discover new drug target for severe asthma and fibrosis.
The search for rare mutations in bacterial genome could lead to better diagnostics and treatments – reducing morbidity caused by the deadly disease.
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
During a webinar, health experts and clinicians highlighted the need for urgent changes to lung cancer services across Europe to create a more cohesive and equal approach to care.
A chip-based infection model developed by Jena researchers enables live microscopic observation of damage to lung tissue caused by the invasive fungal infection aspergillosis.
A proof of concept for a robot that can reach some of the smallest bronchial tubes in the lungs to take tissue samples or deliver cancer therapy.
Scientists have confirmed that an inhaled form of COVID vaccine can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern.
A new pilot study suggests that machine learning algorithms which fuse electrocardiogram (ECG) and electronic health record data may help doctors screen for dangerous, lung-clogging blot clots.
Radiologists in Paris have developed a standardised simple visual lung damage CT severity score for Covid-19 patients who do not have symptoms of severe acute respiratory syndrome (SARS) at the time of initial treatment.
Doctors in Lisbon report on the case of a 61-year-old man who received a double lung transplant after his lungs were irreparably damaged by Covid-19.
Wearables are a trend in respiratory care and many products are being developed to monitor patients remotely. But how much can these tools really help clinicians? An Italian expert discussed current solutions and challenges to their development.
The damage caused by Covid-19 to the lungs’ smallest blood vessels has been intricately captured using high-energy X-rays emitted by a special type of particle accelerator. Scientists from University College London (UCL) and the European Synchrotron Research Facility (ESRF) used a new imaging technology called Hierarchical Phase-Contrast Tomography (HiP-CT), to scan donated human organs,…
